Amgen, Nike Share Gains Contribute To Dow's 350-Point Jump

Dow Jones02:50

DJ Amgen, Nike Share Gains Contribute To Dow's 350-Point Jump

This article was automatically generated by MarketWatch using technology from Automated Insights.

The Dow Jones Industrial Average is climbing Wednesday afternoon with shares of Amgen and Nike delivering strong returns for the price-weighted average.

Shares of Amgen (Amgen Inc.) and Nike (Nike Inc. Cl B) are contributing to the blue-chip gauge's intraday rally, as the Dow (Dow Jones Industrial Average) is trading 352 points (0.7%) higher.

Amgen's shares have climbed $8.38 (2.5%) while those of Nike have risen $1.31, or 2.1%, combining for a roughly 60-point bump for the Dow.

UnitedHealth (UnitedHealth Group Inc.), Goldman Sachs (Goldman Sachs Group Inc.), and American Express (American Express Co.) are also contributing significantly to the gain.

A $1 move in any one of the 30 components of the index equates to a 6.16-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled January 21, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

January 21, 2026 13:50 ET (18:50 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment